Treatment of kidney-allograft rejection with cyclosporin A

Technical requirements for effective regional hydrodynamic gene delivery to the left lateral lobe of the rat liver.

Gene therapy·2010

Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava.

Gene therapy·2007

Cardiovascular function following acute volume overload for hydrodynamic gene delivery to the liver.

Gene therapy·2007

A remarkable permeability of canalicular tight junctions might facilitate retrograde, non-viral gene delivery to the liver via the bile duct.

Gut·2005

In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquine.

Human gene therapy·2002

A powerful cooperative interaction between a fusogenic peptide and lipofectamine for the enhancement of receptor-targeted, non-viral gene delivery via integrin receptors.

The journal of gene medicine·2002

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Elevated asymmetric dimethylarginine drives hematopoietic stem cell metabolic reprogramming and dysfunction in chronic kidney disease.

Experimental cell research·2026

The hidden burden of topical corticosteroid misuse: a systematic review of dermatologic complications.

Current medical research and opinion·2026

Curcumin Delivery Systems for Inflammatory Skin Application: A Review.

Phytotherapy research : PTR·2026

Engineered naringenin-loaded nanoscale coordination polymers for targeted treatment of acute kidney injury.

Materials today. Bio·2026

Modification of the existing maximum residue levels for propyzamide in oilseeds and honey.

EFSA journal. European Food Safety Authority·2026

Pulmonary Arterial Hypertension Associated With Chronic Mephedrone Use: A Case Report.

Pulmonary circulation·2026

Related Experiment Videos

Treatment of kidney-allograft rejection with cyclosporin A

Related Concept Videos

Technical requirements for effective regional hydrodynamic gene delivery to the left lateral lobe of the rat liver.

Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava.

Cardiovascular function following acute volume overload for hydrodynamic gene delivery to the liver.

A remarkable permeability of canalicular tight junctions might facilitate retrograde, non-viral gene delivery to the liver via the bile duct.

In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquine.

A powerful cooperative interaction between a fusogenic peptide and lipofectamine for the enhancement of receptor-targeted, non-viral gene delivery via integrin receptors.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Elevated asymmetric dimethylarginine drives hematopoietic stem cell metabolic reprogramming and dysfunction in chronic kidney disease.

The hidden burden of topical corticosteroid misuse: a systematic review of dermatologic complications.

Curcumin Delivery Systems for Inflammatory Skin Application: A Review.

Engineered naringenin-loaded nanoscale coordination polymers for targeted treatment of acute kidney injury.

Modification of the existing maximum residue levels for propyzamide in oilseeds and honey.

Pulmonary Arterial Hypertension Associated With Chronic Mephedrone Use: A Case Report.

Related Experiment Videos

Treatment of kidney-allograft rejection with cyclosporin A

Related Concept Videos

Related Articles